Literature DB >> 22745613

Long-term outcomes of shamanic treatment for temporomandibular joint disorders.

Nancy H Vuckovic1, Louise A Williams, Jennifer Schneider, Michelle Ramirez, Christina M Gullion.   

Abstract

BACKGROUND: Temporomandibular joint disorders (TMDs) are chronic, often refractory, pain conditions affecting the jaw and face. Patients least likely to respond to allopathic treatment have the most marked biologic responsiveness to external stressors and concomitant psychosocial and emotional difficulties. From a shamanic healing perspective, this describes individuals who are thought to be "dispirited" and may benefit from this ancient form of spiritual healing.
OBJECTIVE: To report on the long-term quantitative and qualitative outcomes relative to end-of-treatment status of a phase I study that evaluated the feasibility and efficacy of shamanic healing for people with TMDs. METHODS/
DESIGN: Participants were contacted by telephone at one, three, six, and nine months after treatment and asked to report pain and disability outcomes and qualitative feedback.
SETTING: Portland, OR. PARTICIPANTS: Twenty-three women aged 25 to 55 years diagnosed with TMD. PRIMARY OUTCOME MEASURES: Participants rated their TMD-related pain and disability (on the TMD Research Diagnostic Criteria Axis II Pain Related Disability and Psychological Status Scale) at each follow-up call and were asked to describe their condition qualitatively.
RESULTS: Improvements in usual pain, worst pain, and functional impairment reported at end of treatment did not change during the 9 months after treatment ended (p > 0.18).
CONCLUSION: Shamanic healing had lasting effects on TMDs in this small cohort of women.

Entities:  

Mesh:

Year:  2012        PMID: 22745613      PMCID: PMC3383158          DOI: 10.7812/tpp/12-004

Source DB:  PubMed          Journal:  Perm J        ISSN: 1552-5767


  29 in total

Review 1.  Reviewing the evidence: can cognitive behavioral therapy improve outcomes for patients with chronic orofacial pain?

Authors:  Vishal R Aggarwal; Martin Tickle; Hanieh Javidi; Sarah Peters
Journal:  J Orofac Pain       Date:  2010

2.  The roles of beliefs, catastrophizing, and coping in the functioning of patients with temporomandibular disorders.

Authors:  J A Turner; S F Dworkin; L Mancl; K H Huggins; E L Truelove
Journal:  Pain       Date:  2001-05       Impact factor: 6.961

3.  THE CANON - 5. Patients and healers in the context of culture: an explorationof the borderland between anthropology, medicine, and psychiatry, by Arthur Kleinman.

Authors:  Mara Buchbinder
Journal:  Anthropol Med       Date:  2013-03-20

Review 4.  Management of TMD: evidence from systematic reviews and meta-analyses.

Authors:  T List; S Axelsson
Journal:  J Oral Rehabil       Date:  2010-04-20       Impact factor: 3.837

5.  Personality characteristics of patients with myofascial pain-dysfunction (MPD) syndrome unresponsive to conventional therapy.

Authors:  R A Schwartz; C S Greene; D M Laskin
Journal:  J Dent Res       Date:  1979-05       Impact factor: 6.116

Review 6.  Mindfulness-based interventions for chronic pain: a systematic review of the evidence.

Authors:  Alberto Chiesa; Alessandro Serretti
Journal:  J Altern Complement Med       Date:  2011-01       Impact factor: 2.579

7.  Long-term efficacy of biobehavioral treatment of temporomandibular disorders.

Authors:  M A Gardea; R J Gatchel; K D Mishra
Journal:  J Behav Med       Date:  2001-08

8.  Shamanism as a healing paradigm for complementary therapy.

Authors:  M Money
Journal:  Complement Ther Nurs Midwifery       Date:  2001-08

9.  Willingness to participate in complementary and alternative medicine clinical trials among patients with craniofacial disorders.

Authors:  Jennifer Schneider; Nancy Vuckovic; Lynn DeBar
Journal:  J Altern Complement Med       Date:  2003-06       Impact factor: 2.579

10.  Electromygraphic biofeedback and tricyclic antidepressants in myofascial pain-dysfunction syndrome: psychological predictors of outcome.

Authors:  A H Gessel
Journal:  J Am Dent Assoc       Date:  1975-11       Impact factor: 3.634

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.